Ac-Glu-pNA

Ac-Glu-pNA is an N-acetylated glutamate-derived amino acid substrate analogue featuring a side-chain carboxyl group and a p-nitroanilide leaving group (pNA). This structure is commonly used in enzyme activity and substrate specificity workflows where release of p-nitroaniline provides a convenient colorimetric readout. As a defined, small-molecule glutamate mimic, Ac-Glu-pNA is typically handled as a laboratory reagent for screening and assay development rather than as a building block for peptide synthesis.

1. Enzyme Activity Assays

Ac-Glu-pNA is widely used as a chromogenic substrate for monitoring protease or peptidase activity in routine enzymology workflows, since cleavage generates p-nitroaniline that can be quantified spectrophotometrically. Researchers in biochemistry and chemical biology labs use it to compare relative catalytic rates across enzyme preparations, buffer conditions, or inhibitor sets, enabling straightforward assay optimization and side-by-side performance evaluation. The N-acetylated glutamate motif helps provide a consistent substrate context for activity measurements, while the pNA reporter supports rapid readout without requiring complex downstream processing.

2. Protease Specificity Screening

Ac-Glu-pNA supports substrate specificity studies where glutamate-recognizing or glutamate-position-dependent enzymes are evaluated using a standardized, commercially available substrate. Protein engineering groups and assay-development teams often incorporate this reagent into panel-style experiments to rank candidate enzymes, assess changes in active-site preferences, or map relative substrate tolerance under controlled conditions. Because the readout is tied to pNA release, it is practical for screening multiple variants or conditions in parallel, including studies focused on how sequence context and terminal modifications influence cleavage behavior.

3. Inhibitor and Kinetics Studies

Ac-Glu-pNA is used to generate kinetic and inhibition data in medicinal chemistry and enzyme inhibitor discovery workflows, where researchers quantify how small molecules alter substrate turnover. By measuring pNA formation over time or across inhibitor concentrations, teams can derive relative inhibition trends and compare inhibitor potency under consistent assay formatting. The defined substrate structure helps reduce variability associated with heterogeneous peptide substrates, making Ac-Glu-pNA a useful tool for early-stage structure-activity relationship work and for establishing assay conditions that translate to more complex substrate formats later in development.

1. Novel Peptide-Based PD1 Immunomodulators Demonstrate Efficacy in Infectious Disease Vaccines and Therapeutics

2. Cationic cell-penetrating peptides are potent furin inhibitors

3. Constitutive and inflammation-dependent antimicrobial peptides produced by epithelium are differentially processed and inactivated by the commensal Finegoldia magna and the pathogen Streptococcus pyogenes

4. The spatiotemporal control of signalling and trafficking of the GLP-1R

5. Myotropic activity and immunolocalization of selected neuropeptides of the burying beetle Nicrophorus vespilloides (Coleoptera: Silphidae)